BG Medicine Inc. | Cash Flow

Fiscal year is January-December. All values USD Thousands.
2011
2012
2013
2014
2015
Net Income before Extraordinaries
17,582.00
23,769.00
15,849.00
8,064.00
6,958.00
Depreciation, Depletion & Amortization
420.00
273.00
165.00
131.00
87.00
Other Funds
20.00
43.00
22.00
2.00
-
Funds from Operations
15,165.00
20,948.00
13,921.00
7,040.00
3,643.00
Changes in Working Capital
199.00
385.00
1,367.00
1,127.00
24.00
Net Operating Cash Flow
14,966.00
21,333.00
15,288.00
8,167.00
3,667.00
Capital Expenditures
93.00
85.00
132.00
-
-
Sale of Fixed Assets & Businesses
-
-
100.00
-
13.00
Net Investing Cash Flow
93.00
85.00
32.00
-
13.00
Issuance/Reduction of Debt, Net
100.00
9,744.00
2,533.00
4,480.00
2,484.00
Net Financing Cash Flow
36,508.00
10,330.00
10,285.00
4,539.00
1,056.00
Net Change in Cash
21,449.00
11,088.00
5,035.00
3,628.00
2,598.00
Free Cash Flow
15,059.00
21,418.00
15,420.00
8,167.00
3,667.00
Change in Capital Stock
36,588.00
543.00
12,796.00
9,017.00
3,540.00

About BG Medicine

View Profile
Address
124 Washington Street
Foxboro Massachusetts 02035
United States
Employees -
Website http://www.bg-medicine.com
Updated 07/08/2019
BG Medicine, Inc. engages in the research and development, clinical research, manufacture and sale of diagnostic products for heart failure and related disorders. It distributes its products such as BGM Galectin-3 to clinical laboratories, hospitals and health care provider. The company was founded in February 2000 and is headquartered in Waltham, MA.